BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28787698)

  • 1. LncRNA MEG3 has anti-activity effects of cervical cancer.
    Wang X; Wang Z; Wang J; Wang Y; Liu L; Xu X
    Biomed Pharmacother; 2017 Oct; 94():636-643. PubMed ID: 28787698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity.
    Gu L; Zhang J; Shi M; Zhan Q; Shen B; Peng C
    Biomed Pharmacother; 2017 May; 89():1269-1276. PubMed ID: 28320094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K.
    Guo HM; Yang SH; Zhao SZ; Li L; Yan MT; Fan MC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4090-4097. PubMed ID: 30024596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway.
    Zhang Y; Xiang C; Wang Y; Duan Y; Liu C; Jin Y; Zhang Y
    Biomed Pharmacother; 2017 Oct; 94():644-651. PubMed ID: 28787699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
    Ji L; Li X
    J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
    Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA GHET1 suppresses cervical carcinoma in vitro and in vivo.
    Ling W; Yangchun X; Wei W; Qiang W
    Cancer Biomark; 2020; 28(1):21-32. PubMed ID: 32176622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.
    Wang J; Xu W; He Y; Xia Q; Liu S
    Inflamm Res; 2018 Dec; 67(11-12):927-936. PubMed ID: 30310931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-205 as a biological marker in non-small cell lung cancer.
    Duan B; Guo T; Sun H; Cai R; Rui Q; Xi Z
    Biomed Pharmacother; 2017 Jul; 91():823-830. PubMed ID: 28501009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.
    Wu JL; Meng FM; Li HJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5938-5945. PubMed ID: 30280775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MEG3 inhibits proliferation and promotes apoptosis of synovial cells in rats with knee osteoarthritis by regulating PTEN.
    Han K; Wang FR; Yu MQ; Xu B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5242-5248. PubMed ID: 32495857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MEG3 participates in neuronal cell injury induced by subarachnoid hemorrhage via inhibiting the Pi3k/Akt pathway.
    Liang Z; Chi YJ; Lin GQ; Xiao LF; Su GL; Yang LM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2824-2831. PubMed ID: 29771435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
    Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.